All lobbying filings

HART HEALTH STRATEGIES

HART HEALTH STRATEGIES filed a Q4 termination report for STIMLABS on January 16, 2026, reporting $30,000 in lobbying income.

Lobbying for STIMLABS · Tissue Bank

All filings by HART HEALTH STRATEGIES · Everything STIMLABS has reported

Filing · LD-2 quarterly report Q4 termination

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 16, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Georgia

Representation ended

Dec 31, 2025

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Monitoring Healthcare Regulations and Legislation

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.